Health Catalyst Q3 revenue $68.4M (+11% YoY), beats guidance; raises FY2022 outlook

Health Catalyst, Inc.

2022-Q3 EPS reported -$1.97 revenue$207,074,000

Total revenue $68.4M (+11% YoY); technology revenue $43.9M (+15%), professional services $24.4M (+4%).
GAAP net loss $45.7M; adjusted EBITDA loss $4.6M, improving 21% YoY.
Raised full-year 2022 revenue and adjusted EBITDA guidance; dollar-based retention now expected 97-101%.
CEO Dan Burton highlighted strong pipeline and cost reduction efforts ahead of schedule.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the quarter ended September 30, 2022 results: revenue $68,354, net income $(45,735). Guidance raised.

Period: the quarter ended September 30, 2022
Revenue: $68,354
Net income: $(45,735)
Guidance: raised
Result: reported results

Exact text from the filing

GAAP Financial Data: (in thousands, except percentages, unaudited) Technology revenue $ 43,997 $ 38,262 15% Professional services revenue $ 24,357 $ 23,475 4% Total revenue $ 68,354 $ 61,737 11% Loss from operations $ (45,721) $ (42,249) (8)% Net loss $ (45,735) $ (40,014) (14)% Other Non-GAAP Financial Data: (1) Adjusted Technology Gross Profit $ 29,993 $

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-22-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.